Lack of expression of transforming growth factor-β type II receptor associated with malignant progression in human salivary gland cell clones
Authors:
- 11 June 1996
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 66 (6) , 802-805
Abstract
To understand the molecular mechanisms whereby normal human salivary gland cells become malignant and escape growth‐inhibitory control by transforming growth factor (TGF)‐β1, we examined the effect of TGF‐β1 on the proliferation and expression of TGF‐β receptors in cells and the expression of TGF‐β type II receptor (TβR‐II) mRNA. An SV40‐immortalized normal human salivary gland duct cell clone (NS‐SV‐DC) with no tumorigenic ability, originally obtained via s.c. implantation into nude mice, was partially resistant to the growth‐inhibitory effect of TGF‐β1, while a neoplastic human salivary gland duct cell clone (HSGc) with tumorigenic, but not metastatic, potential in nude mice was more resistant to the growth‐suppressive effect of TGF‐β1 than NS‐SV‐DC. Metastatic cell clones derived from carcinogen‐treated HSGc were completely refractory to the anti‐proliferative effect of TGF‐β1. Affinity cross‐linking revealed that NS‐SV‐DC possesses the types I, II (TβR‐II) and III receptors. However, HSGc and metastatic cell clones lacked expression of detectable levels of the TβR‐II protein. Moreover, we evaluated TβR‐II mRNA expression in these cell clones by Northern blot analysis and observed that, although NS‐SV‐DC expressed a large amount of TβR‐II mRNA, a small amount of TβR‐II mRNA was detectable in HSGc. In contrast, no significant bands were detected in metastatic cell clones. Our results, therefore, suggest that one of the possible mechanisms of escape from autocrine or paracrine growth inhibition by TGF‐β1 during human salivary gland carcinogenesis involves reduced expression or lack of TβR‐II. © 1996 Wiley‐Liss, Inc.Keywords
This publication has 18 references indexed in Scilit:
- Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.Molecular and Cellular Biology, 1994
- Close Correlation between the Dephosphorylation of p53 and Growth Suppression by Transforming Growth Factor-β1 in Nasopharyngeal Carcinoma Cells Transduced with Adenovirus Early Region GenesJapanese Journal of Cancer Research, 1994
- Cloning of a TGF$beta; type I receptor that forms a heteromeric complex with the TGF$beta; type II receptorCell, 1993
- Inactivation of the Type II Receptor Reveals Two Receptor Pathways for the Diverse TGF-β ActivitiesScience, 1993
- Involvement of p53 mutation in the development of human salivary gland pleomorphic adenomasCancer Letters, 1992
- Control of junB and extracellular matrix protein expression by transforming growth factor-beta 1 is independent of simian virus 40 T antigen-sensitive growth-sensitive growth-inhibitory events.Molecular and Cellular Biology, 1991
- A genetic model for colorectal tumorigenesisCell, 1990
- Biological effects and binding properties of transforming growth factor-β on human oral squamous cell carcinoma cellsExperimental Cell Research, 1990
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1984
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970